JOURNAL ARTICLE
Frequency-doubled Nd:YAG laser treatment for premacular hemorrhage.
Ophthalmic Surgery, Lasers & Imaging 2003 July
BACKGROUND AND OBJECTIVE: Premacular hemorrhage occurs as a result of Valsalva retinopathy, proliferative diabetic retinopathy, and retinal artery macroaneurysm and may cause sudden, profound visual loss. Currently, it is managed with observation or vitrectomy. An alternative method of treatment is by Nd:YAG laser or argon laser membranotomy. This study investigates the efficacy of frequency-doubled Nd:YAG laser membranotomy.
PATIENTS AND METHODS: Twelve patients had frequency-doubled Nd:YAG laser membranotomy as a two-step procedure to drain premacular hemorrhage: two stretch burns to make the membrane stable and taut and then placement of penetration burns between stretch burns. The follow-up period was 18 months.
RESULTS: Ten eyes had marked clearing of hemorrhage and immediate improvement of vision following the laser treatment. One eye with retinal macroaneurysm and another with proliferative diabetic retinopathy did not show marked improvement immediately following membranotomy.
CONCLUSION: Frequency-doubled Nd:YAG membranotomy is a safe, simple, and noninvasive alternative to conservative treatment or vitrectomy and allows faster resolution of premacular hemorrhage.
PATIENTS AND METHODS: Twelve patients had frequency-doubled Nd:YAG laser membranotomy as a two-step procedure to drain premacular hemorrhage: two stretch burns to make the membrane stable and taut and then placement of penetration burns between stretch burns. The follow-up period was 18 months.
RESULTS: Ten eyes had marked clearing of hemorrhage and immediate improvement of vision following the laser treatment. One eye with retinal macroaneurysm and another with proliferative diabetic retinopathy did not show marked improvement immediately following membranotomy.
CONCLUSION: Frequency-doubled Nd:YAG membranotomy is a safe, simple, and noninvasive alternative to conservative treatment or vitrectomy and allows faster resolution of premacular hemorrhage.
Full text links
Trending Papers
Clinical Evidence and Proposed Mechanisms for Cardiovascular and Kidney Benefits from Sodium-Glucose Co-transporter-2 Inhibitors.TouchREVIEWS in endocrinology. 2022 November
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app